[Antimicrobial effectiveness of azlocillin in cholesteatoma in parenteral administration].
Azlocillin has a broad spectrum particularly against pseudomonas and should therefore be useful for preoperative parenteral treatment of infected cholesteatomas in those cases which cannot be controlled by local therapy. To determine the efficacy in treatment of cholesteatoma the concentration of azlocillin in separate tissue fractions of cholesteatoma matrix, cholesteatoma debris and granulation tissue surrounding cholesteatoma was determined. In 9 cases 2 g azlocillin was injected and in 5 cases 4 g. The concentration drop between the different tissue fractions was equal in all cases. However, as clinical experience has shown, differing high levels of azlocillin were found in comparable tissue fractions of the 14 cholesteatomas. In some of the cases the minimal antibacterial activity was not attained in the cholesteatoma fractions.
Mertens
J
J
Klinik und Poliklinik für Hals-Nasen-Ohrenkrankheiten, Universität Kiel.
Wustrow
J
J
Ullmann
U
U
D001390:Azlocillin / Q000008:administration & dosage*; D001424:Bacterial Infections / Q000188:drug therapy; D002781:Cholesteatoma / Q000188:drug therapy* / Q000601:surgery; D006801:Humans; D007262:Infusions, Intravenous; D008826:Microbial Sensitivity Tests; D010033:Otitis Media / Q000188:drug therapy* / Q000601:surgery; D011292:Premedication
D001390:Azlocillin
Die antimikrobielle Wirksamkeit von Azlocillin in Cholesteatomen bei parenteraler Applikation.